ici 204,219 has been researched along with arachidonic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hamanaka, N; Nakai, H | 1 |
Capella, GL | 1 |
Groneberg, DA; Schmidt, R; Staats, P; Wagner, U | 1 |
Citron, F; Deem, AK; Genovese, G; Perelli, L; Viale, A | 1 |
1 review(s) available for ici 204,219 and arachidonic acid
Article | Year |
---|---|
[Leukotriene D4 antagonists].
Topics: Arachidonic Acid; Chromones; Drug Design; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Membrane Proteins; Phenylcarbamates; Receptors, Leukotriene; SRS-A; Sulfonamides; Tosyl Compounds | 2000 |
3 other study(ies) available for ici 204,219 and arachidonic acid
Article | Year |
---|---|
Anti-leukotriene drugs in the prevention and treatment of hepatorenal syndrome.
Topics: Acetates; Arachidonic Acid; Cyclopropanes; Hepatorenal Syndrome; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leukotrienes; Liver; Phenylcarbamates; Protein Structure, Tertiary; Quinolines; Sulfides; Sulfonamides; Thromboxanes; Tosyl Compounds | 2003 |
The cysteinyl-leukotriene-1 receptor antagonist zafirlukast is a potent secretagogue in rat and human airways.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetates; Animals; Arachidonic Acid; Bronchi; Chromones; Cyclooxygenase Inhibitors; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Ibuprofen; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Membrane Proteins; Morpholines; Phenylcarbamates; Phosphoinositide-3 Kinase Inhibitors; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds; Trachea | 2005 |
Leukotrienes, a potential target for Covid-19.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betacoronavirus; Coronavirus Infections; COVID-19; Cyclopropanes; Cytokine Release Syndrome; Humans; Hydroxyurea; Immunologic Factors; Indoles; Leukotrienes; Pandemics; Phenylcarbamates; Pneumonia, Viral; Quinolines; SARS-CoV-2; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2020 |